tiprankstipranks
Trending News
More News >
Whitehawk Therapeutics (WHWK)
NASDAQ:WHWK
US Market
Advertisement

Whitehawk Therapeutics (WHWK) Financial Statements

Compare
486 Followers

Whitehawk Therapeutics Financial Overview

Whitehawk Therapeutics's market cap is currently $85.30M. The company's EPS TTM is $-0.76; its P/E ratio is 12.00; Whitehawk Therapeutics is scheduled to report earnings on August 7, 2025, and the estimated EPS forecast is $-0.51. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 25.98M$ 24.35M$ 15.22M$ 1.12M$ 14.58M
Gross Profit$ -28.07M$ -27.38M$ -18.78M$ -18.55M$ -428.00K
Operating Income$ -67.46M$ -71.93M$ -62.68M$ -111.22M$ -2.55M
EBITDA$ -64.63M$ -71.76M$ -58.80M$ -36.96M$ -2.54M
Net Income$ -63.69M$ -65.77M$ -60.51M$ -110.09M$ -3.48M
Balance Sheet
Cash & Short-Term Investments$ 47.24M$ 108.84M$ 172.56M$ 148.99M$ 4.46M
Total Assets$ 70.32M$ 132.42M$ 184.24M$ 157.91M$ 18.82M
Total Debt$ 833.00K$ 1.27M$ 1.66M$ 605.00K$ 10.26M
Net Debt$ -27.84M$ -61.62M$ -37.36M$ -148.38M$ 5.80M
Total Liabilities$ 17.84M$ 27.23M$ 25.86M$ 21.50M$ 31.26M
Stockholders' Equity$ 52.48M$ 105.19M$ 158.38M$ 136.41M$ -12.43M
Cash Flow
Free Cash Flow$ -61.20M$ -63.63M$ -50.08M$ -22.47M$ -12.70M
Operating Cash Flow$ -59.55M$ -59.66M$ -49.64M$ -22.42M$ -12.70M
Investing Cash Flow$ 25.20M$ 83.21M$ -132.89M$ 25.15M$ 0.00
Financing Cash Flow$ 130.00K$ 326.00K$ 72.62M$ 141.80M$ 1.19M
Currency in USD

Whitehawk Therapeutics Earnings and Revenue History

Whitehawk Therapeutics Debt to Assets

Whitehawk Therapeutics Cash Flow

Whitehawk Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis